NIR‐Activated Ag 2 S Quantum Dots for Synergistic Immunomodulation and Precision Therapy of Refractory Osteomyelitis
Advanced Healthcare Materials · 04.11.2026
DOI: 10.1002/adhm.71953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 04.11.2026. Verfasst von Rui Yao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the Clinical Trials Fund of the Nanjing Drum Tower Hospital, Nanjing, China, the Orthopedic Clinical Medical Center Project of Jiangsu Province's Thirteenth Five-Year Plan for Strengthening Medical and Healthcare Services, Nanjing, China.
Abstract (Originalsprache)
Staphylococcus aureus ( S. aureus ) is a predominant clinical pathogen responsible for a wide range of infections. By forming biofilms during infection, S. aureus evades conventional therapies, leading to persistent infections and treatment failure. To address this challenge, we employed silver sulfide quantum dots (Ag 2 S QDs) for near‐infrared (NIR) phototherapy. In vitro, the nanoagent achieved >99.99% killing of S. aureus within 10 minutes and reduced biofilm biomass by >58%. In a murine osteomyelitis model, a single NIR treatment reduced bacterial loads by 71.83% on implants and 59.18% in bone tissue, while also suppressing key inflammatory cytokines, with local macrophage polarization shifting from an M1‐dominant to an M2‐dominant phenotype. Histopathological and micro‐CT analyses indicated attenuated bone destruction. The nanoagent showed favorable biosafety, with no systemic toxicity in major organs and osteoblast viability >75% at therapeutic concentrations. Together, these results demonstrate a phototherapeutic strategy with combined antibacterial and anti‐biofilm effects, supporting its potential as an adjuvant approach for managing refractory osteomyelitis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
- State Key Laboratory of Coordination Chemistry, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China.
- Department of Orthopedics, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, China.
- School of Life Sciences, Nanjing University, Nanjing, China.
- Nanchuang (Jiangsu) Institute of Chemistry and Health, Nanjing, China.
ORCID-Profile: Peiqing Sun, Wei Wei, Jing Zhao, Xusheng Qiu
Förderung
- National Natural Science Foundation of China
- the Clinical Trials Fund of the Nanjing Drum Tower Hospital, Nanjing, China
- the Orthopedic Clinical Medical Center Project of Jiangsu Province's Thirteenth Five-Year Plan for Strengthening Medical and Healthcare Services, Nanjing, China
Zitieren
APA
Yao, R., Sun, P., Liu, Y., Hailipitimu, W., Chen, Y., Lei, Z., Wang, L., Yu, J., Wei, W., Zhao, J., & Qiu, X. (2026). NIR‐Activated Ag 2 S Quantum Dots for Synergistic Immunomodulation and Precision Therapy of Refractory Osteomyelitis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71953
Vancouver
Yao R, Sun P, Liu Y, Hailipitimu W, Chen Y, Lei Z, et al. NIR‐Activated Ag 2 S Quantum Dots for Synergistic Immunomodulation and Precision Therapy of Refractory Osteomyelitis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71953
BibTeX
@article{Yao2026,
author = {Yao, Rui and Sun, Peiqing and Liu, Ying and Hailipitimu, Wusimanjiang and Chen, Yaxin and Lei, Zhijie and Wang, Li and Yu, Jianglin and Wei, Wei and Zhao, Jing and Qiu, Xusheng},
title = {NIR‐Activated Ag 2 S Quantum Dots for Synergistic Immunomodulation and Precision Therapy of Refractory Osteomyelitis},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71953}
}
EUVIMED